A Single Infusion of Zoledronate in Postmenopausal Women Following Denosumab Discontinuation Results in Partial Conservation of Bone Mass Gains
Author:
Affiliation:
1. OsteoRheuma Bern Bern Switzerland
2. Department of Rheumatology, Immunology and AllergologyUniversity Hospital Bern Switzerland
3. Institute for Social and Preventive Medicine Bern Switzerland
Publisher
Wiley
Subject
Orthopedics and Sports Medicine,Endocrinology, Diabetes and Metabolism
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1002/jbmr.3962
Reference27 articles.
1. Effects of Denosumab Treatment and Discontinuation on Bone Mineral Density and Bone Turnover Markers in Postmenopausal Women with Low Bone Mass
2. Effect of denosumab on bone density and turnover in postmenopausal women with low bone mass after long-term continued, discontinued, and restarting of therapy: A randomized blinded phase 2 clinical trial
3. Multiple clinical vertebral fractures following denosumab discontinuation
4. Severe spontaneous vertebral fractures after denosumab discontinuation: three case reports
5. Severe Rebound-Associated Vertebral Fractures After Denosumab Discontinuation: 9 Clinical Cases Report
Cited by 64 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Follow-up bone mineral density testing: 2023 official positions of the International Society for Clinical Densitometry;Journal of Clinical Densitometry;2024-01
2. The comparison of alendronate and raloxifene after denosumab (CARD) study: A comparative efficacy trial;Osteoporosis International;2023-10-06
3. Similarities and Differences in the Management of Patients with Osteoporotic Vertebral Fractures and Those with Rebound-Associated Vertebral Fractures Following Discontinuation of Denosumab;Journal of Clinical Medicine;2023-09-10
4. Sequential Therapy for the Long-Term Treatment of Postmenopausal Osteoporosis;The Journal of Clinical Endocrinology & Metabolism;2023-08-23
5. The Five-Year Effect of a Single Zoledronate Infusion on Bone Mineral Density Following Denosumab Discontinuation in Women with Postmenopausal Osteoporosis;Calcified Tissue International;2023-08-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3